Envarsus XR 1 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DX25F6QLR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,289
Award facts
- Contract value 100% obligated
- $1,288.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, valued at $1,288.86 for the supply of Envarsus XR 1 mg tablets (100-count units) to the Department of Defense Medical Supply Chain. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 11, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs.
The Defense Logistics Agency's Medical Supply Chain procures pharmaceutical products and medical supplies critical to supporting Department of Defense medical readiness and veteran healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its role as a key vendor for military pharmaceutical procurement, supplying specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This specific delivery order for Envarsus XR, an immunosuppressant medication, reflects the company's ongoing capability to fulfill federal medical supply requirements through competitive procurement mechanisms.
Quick answers
Who was awarded contract SPE2DX25F6QLR?
SPE2DX25F6QLR was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on June 18, 2025.
How much is contract SPE2DX25F6QLR worth?
The government has obligated $1,289 on SPE2DX25F6QLR.
Is contract SPE2DX25F6QLR an order under another contract?
Yes. SPE2DX25F6QLR is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6QLR competed?
The extent of competition for SPE2DX25F6QLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award